Zudena-100 mg (Udenafil)
Zudena-100 is a drug used in urology for the treatment of erectile dysfunction. It belongs to a class of drugs called a PDE5 inhibitor, which also includes many other erectile dysfunction drugs such as avanafil, sildenafil, tadalafil and vardenafil. It was developed by Dong-A Pharmaceutical and is marketed under the Udzire brand. With a maximum plasma concentration reached after 1.0-1.5 hours and a half-life of 11 to 13 hours (a relatively rapid onset and long duration of action), both on-demand and daily use of Zudena-100. Typical doses are 100 and 200 mg.
Erectile dysfunction (ED) is an inability to achieve or maintain an erection suitable for sexual intercourse. Hologologists say at least 10% of men in India may have to use these drugs at some point. Studies have shown that 40% of men up to age 40 have ED and it goes to 70% for 60 years. Commonly prescribed drugs for the disorder in India are sildenafil (Viagra) and tadalafil, which belong to a category called phosphodiesterasetype5 drugs. Now, Zydus, a pharmaceutical company, has exclusive permission to sell udenafil. The release of a drug is not always celebrated by many, especially men. A drug that was released in India last week is the latest in the drug list that has a cure for erectile dysfunction. Manufacturers claim that Zudena-100, which will be marketed under the Udezire brand, will be long-acting, but with minimal side effects.
Erectile dysfunction (ED) is an inability to achieve or maintain an erection suitable for sexual intercourse.Hologologists say at least 10% of men in India may have to use these drugs at some point. Studies have shown that 40% of men up to age 40 have ED and 70% rise by age 60.Zudena-100 has a trade name Udzire. This is one of the four famous molecules studied for the treatment of erectile dysfunction (ED). It is known with proven clinical efficacy, high safety and patient acceptability. The unique qualities of Udzire make it the perfect choice for the user.
Udzire provides a quick and strong onset of action, lasting up to twenty-four hours. Udzire has no testicular toxicity. Of course, all of these properties will be the best in its segment. Zudena-100 is available in oval-shaped, film-coated tablets that are light pink with light yellow tints. It is stamped with the 100 symbol on one side and the Z and Y symbols on the other
1 tablet contains 100 mg of udenafil,
There are one or four tablets per pack.
Hearing greatly improves erection and the chance for successful sexual intercourse. The action of the drug has an optimal duration of up to twenty-four hours. The effect appears after thirty minutes after taking the drug in the presence of excessive arousal.
Power of regulators
The composition and the form
Udenafil 100mg film-coated tablets, adjuvants: lactose, corn starch, colloidal silicon dioxide, L-hydroxypropylcellulose, hydroxypropyl-LF, talc, magnesium stearate, Coating: hydroxypropylmethylcellulose, talc, red iron oxide, yellow iron oxide , titanium dioxide, strips packs 1, 2 or 4 pieces., in carton pack 1 (for 1 or 4 pieces) or 2 (for 2 pieces). Light pink coated tablets with a yellow tinge, oval embossed with the symbol 100 on one side and symbols in the form of the letters 'Z' and 'Y', risk sharing on the other.At the break a white or almost white.
Improve erectile function.
Indications of Udenafil
Treatment of erection disorders, characterized by the inability to achieve or maintain a penile erection sufficient for satisfactory sexual intercourse.
Oral Ludenafil is rapidly absorbed and produces effects within 30-90 minutes (average 60 minutes). The life span of Udenafil is 12 hours, due to high plasma protein binding (93.9%), which extends up to 24 hours after single dose administration. Alcohol and food have no effect on the absorbability of udenafil. Drinking 112 ml alcohol (equivalent to 40% ethyl alcohol) in combination with oral udenafil a dose of 200 mg does not affect the pharmacokinetic profile of udenafil. LUdenafil does not accumulate in the body, even continuous intake does not produce significant changes in its pharmacokinetics.